Catalyst Pharmaceuticals Inc. closed $2.35 short of its 52-week high ($24.27), which the company reached on November 8th.

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) yesterday and set a ...

Professor Douglas Boateng, Board Chairman of the Minerals Income Investment Fund (MIIF), has underscored the potential of ...

We recently published a list of 10 Companies Mirror Wall Street Downturn. In this article, we are going to take a look at ...

The highly anticipated fourth edition of the Future Minerals Forum, set to take place from January 14 to 16, 2025, in Riyadh, ...

Catalyst Energy Infrastructure Fund earns a Below Average Process Pillar rating. The process is bolstered by the fund's impressive long-term risk-adjusted performance. This can be seen in its five ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The U.S. dollar rallied on Friday after data showed the world's largest economy created more jobs than expected last month, reinforcing expectations that the Federal Reserve will pause its rate ...

Supreme Court Seems Poised to Uphold Law That Could Ban TikTok The justices are expected to rule quickly in the case, which pits national security concerns about China against free speech ...

Newsom Orders Inquiry Into Why L.A. Firefighters Ran Out of Water In one of L.A.’s richest ZIP codes, food service workers also lost their homes. One Altadena resident is being the ‘eyes on ...

At Novartis, we are reimagining medicine to improve and extend people’s lives. We are working hard to produce breakthroughs and address unmet needs for patients with devastating diseases, including ...